(reprint from Biospace, published: Jun 03, 2022) Immunocore announcesclinical trial collaboration with Sanofito evaluate Sanofi’s product candidate SAR444245, non-alpha IL-2,in combination with KIMMTRAK® in patients with metastatic cutaneous…

(reprint from Targeted Oncology, published: Jun 05, 2022) Adjuvant Pembrolizumab Significantly Improves DMFS and RFS in Patients with Stage II…

Dr. Zeynep Eroglu is a medical oncologist at Moffitt Cancer Center in Florida. Dr. Eroglu’s research interests are translational and…

TISSUE IS THE ISSUE AIM at Melanoma’s major research initiative—the International Melanoma Tissue Bank Consortium (IMTBC)—is the first of its…

By Erin Bekes In a study by Dr. Antoine Eskander and colleagues described in the Journal of the National Comprehensive…

By Kim Margolin, M.D., FACP, FASCO Background about melanoma and other malignancies involving the brain Of all the kinds of…

By Kim Margolin, M.D., FACP, FASCO The vast majority of people diagnosed with cutaneous melanoma are cured by one or…

In today’s busy medical practices, you need to be involved in your own care (or that of a loved one)…

by Mara Klecker Most of Claudia Piazza Cidonio’s family studied medicine and went on to become doctors – something she…

By Mara Klecker Shannon Eberly is fair-skinned and freckled, but she never had a mole on her skin that looked…